HDAC9 and invasive breast carcinoma: Yan M. et al. [53] have demonstrated that class I HDAC members associate negatively with CD8+ effector T cells, NK, and NKT cells in gynecologic cancers, including BRCA, CESC, OV, and UCEC tumors.